Paragon Capital Management LLC Bausch Health Companies Inc. Transaction History

Paragon Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$7.06 - $23.63 $70,359 - $235,496	-9,966 Reduced 14.62%	58,191 $486,000
Q1 2022 May 11, 2022	BUY	$21.6 - $27.79 $26,632 - $34,265	1,233 Added 1.84%	68,157 $1.56 Million
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $50,278 - $63,415	-2,186 Reduced 3.16%	66,924 $1.85 Million
Q3 2021 Nov 10, 2021	SELL	$25.04 - $30.06 $79,426 - $95,350	-3,172 Reduced 4.39%	69,110 $1.93 Million
Q2 2021 Aug 11, 2021	SELL	$27.43 - $32.7 $25,180 - $30,018	-918 Reduced 1.25%	72,282 $2.12 Million
Q1 2021 Apr 30, 2021	SELL	$21.37 - $34.38 $26,242 - $42,218	-1,228 Reduced 1.65%	73,200 $2.17 Million
Q4 2020 Jan 21, 2021	SELL	$15.31 - $21.12 $13,396 - $18,480	-875 Reduced 1.16%	74,428 $1.55 Million
Q3 2020 Oct 21, 2020	SELL	$14.88 - $20.13 $3,243 - $4,388	-218 Reduced 0.29%	75,303 $1.17 Million
Q2 2020 Aug 03, 2020	BUY	$13.31 - $20.51 $1.01 Million - $1.55 Million	75,521 New	75,521 $1.38 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Paragon Capital Management LLC with notifications on news.